Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats

Psychopharmacology

Volumn 179, Issue 3, 2005, Pages 576-586

  Solinas, Marcello ^a   Ferré, Sergi ^a   Antoniou, Katerina ^b   Quarta, Davide ^a   Justinova, Zuzana ^a   Hockemeyer, Jörg ^c   Pappas, Lara A ^a   Segal, Pavan N ^a   Wertheim, Carrie ^a   Müller, Christa E ^c   Goldberg, Steven R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Adenosine receptors; Binding; Caffeine; Dopamine; Drug discrimination; Glutamate

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE 2B RECEPTOR; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; CAFFEINE; METHAMPHETAMINE; MSX 3; PHOSPHORIC ACID MONO[3 [8 [2 (3 METHOXYPHENYL)VINYL] 7 METHYL 2,6 DIOXO 1 PROP 2 YNYL 1,2,6,7 TETRAHYDROPURIN 3 YL]PROPYL]ESTER DISODIUM; RADIOLIGAND; ROLIPRAM; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELL LINE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG SELECTIVITY; EXPERIMENT; GENETIC TRANSFECTION; INJECTION; MALE; MAMMAL CELL; MEMBRANE; NONHUMAN; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; STIMULUS; TRAINING; ANIMAL; BRAIN; CHEMISTRY; COMPARATIVE STUDY; DISCRIMINATION LEARNING; DOSE RESPONSE; DRUG ANTAGONISM; HUMAN; PHYSIOLOGY; REACTION TIME; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; CAFFEINE; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTOR, ADENOSINE A1;

EID: 21044438441     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2081-6     Document Type: Article

References (33)

1. 3H]NECA in rat striatal membranes. Mol Pharmacol 29:331-346
2. Daly JW, Fredholm BB (1998) Caffeine - an atypical drug of dependence. Drug Alcohol Depend 51:199-206
3. Evans SM, Critchfield TS, Griffiths RR (1994) Caffeine reinforcement demonstrated in a majority of moderate caffeine users. Behav Pharmacol 5:231-238
4. Ferré S, Fuxe K, von Euler G, Johansson B, Fredholm BB (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51:501-512
5. Ferré S, Fredholm BB, Morelli M, Popoli P, Fuxe K (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20:482-487
6. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83-133
7. Fredholm BB, Irenius E, Kull B, Schulte G (2001) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 61:443-448
8. 6-phenylisopropyl-adenosine and antagonism by caffeine. Psychopharmacology 87:272-277
9. Griffiths RR, Woodson PP (1988) Reinforcing properties of caffeine: studies in humans and laboratory animals. Pharmacol Biochem Behav 29:419-427
10. Griffiths RR, Bigelow GE, Liebson IA (1989) Reinforcing effects of caffeine in coffee and capsules. J Exp Anal Behav 52:127-140
11. Griffiths RR, Evans SM, Heishman SJ, Preston KL, Sannerud CA, Wolf B, Woodson PP (1990) Low-dose caffeine discrimination in humans. J Pharmacol Exp Ther 252:970-978
12. 2B-selective adenosine receptor antagonists. J Med Chem 45:1500-1510
13. Holtzman SG (1986) Discriminative stimulus properties of caffeine in the rat: noradrenergic mediation. J Pharmacol Exp Ther 239:706-714
14. Jacobson KA, Nikodijevic O, Padgett WL, Gallo-Rodriguez C, Maillard M, Daly JW (1993) 8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo. FEBS Lett 323:141-144
15. Justinova Z, Ferre S, Segal PN, Antoniou K, Solinas M, Pappas LA, Highkin JL, Hockemeyer J, Munzar P, Goldberg SR (2003) Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats. J Pharmacol Exp Ther 307:977-986
16. Kamien JB, Bickel WK, Hughes JR, Higgins ST, Smith BJ (1993) Drug discrimination by humans compared to nonhumans: current status and future directions. Psychopharmacology 111:259-270
17. Karcz-Kubicha M, Antoniou K, Terasmaa A, Quarta D, Solinas M, Justinova Z, Pezzola A, Reggio R, Muller E, Fuxe K, Goldberg R, Popoli P, Ferre S (2003) Involvement of adenosine A(1) and A (2A) receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology 28:1281-1291
18. Kim SA, Marshall MA, Melman N, Kim HS, Müller CE, Linden J, Jacobson KA (2002) Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions. J Med Chem 45 (11):2131-2138
19. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, Costentin J, Heath JK, Vassart G, Parmentier M (1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388:674-678
20. Müller CE, Geis U, Hipp J, Schobert U, Frobenius W, Pawlowski M, Suzuki F, Sandoval-Ramirez J (1997) Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists. J Med Chem 40:4396-4405
21. 2A adenosine receptors. Eur J Pharm Sci 10:259-265
22. Mumford GK, Holtzman SG (1991) Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat. J Pharmacol Exp Ther 258:857-865
23. Nikodijevic O, Sarges R, Daly JW, Jacobson KA (1991) Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism. J Pharmacol Exp Ther 259:286-294
24. 3 adenosine receptor. Mol Pharmacol 45:978-982
25. Powell KR, Koppelman LF, Holtzman SG (1999) Differential involvement of dopamine in mediating the discriminative stimulus effects of low and high doses of caffeine in rats. Behav Pharmacol 10:707-716
26. Quarta D, Ferré S, Solinas M, You Z-B, Hockemeyer J, Popoli P, Goldberg SR (2004) Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J Neurochem 88:1151-1158
27. 2A-selective adenosine receptor antagonists. J Med Chem 43:440-448
28. Schuster CR, Johanson CE (1988) Relationship between the discriminative stimulus properties and subjective effects of drugs. Psychopharmacol Ser 4:161-175
29. Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci U S A 78:3260-3264
30. Solinas M, Ferré S, You ZB, Karcz-Kubicha M, Popoli P, Goldberg SR (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci 22:6321-6324
31. van Galen PJ, van Bergen AH, Gallo-Rodriguez C, Melman N, Olah ME, Ijzerman AP, Stiles GL, Jacobson KA (1994) A binding site model and structure-activity relationships for the rat A3 adenosine receptor. Mol Pharmacol 45:1101-1111
32. Yamamoto T, Miyamoto K, Ueki S (1987) Rolipram as a discriminative stimuli: transfer to phosphodiesterase inhibitors. Jpn J Pharmacol 43:165-171
33. Yan L, Müller CE (2004) Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: towards the development of sulfonic acid prodrugs with peroral bioavailability. J Med Chem 47(4):1031-1043